SCHEDULE: BlackRock Reports 8.4% Stake in Sotera Health

BlackRock, Inc. has disclosed a beneficial ownership of 8.4% in Sotera Health Co. as of June 30, 2026.

Summary

• BlackRock, Inc. has filed a Schedule 13G, indicating its beneficial ownership of Sotera Health Co. common stock.
• The filing, an amendment to a previous filing, shows BlackRock beneficially owns 23,845,504 shares.
• This represents 8.4% of the class of securities.
• BlackRock has sole voting power over 23,160,503 shares and sole dispositive power over 23,845,504 shares.
• The filing clarifies that this ownership is held in the ordinary course of business and not for the purpose of influencing control of the issuer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. It's a routine disclosure of institutional ownership and does not inherently signal positive or negative performance for Sotera Health Co.

Positives

• BlackRock, a significant institutional investor, holds a substantial stake in Sotera Health Co., suggesting confidence in the company's long-term prospects.
• The ownership is reported as being in the ordinary course of business, implying a standard investment approach rather than a hostile takeover attempt.

Risks

• The filing does not contain specific risk factors related to Sotera Health Co. itself, as it is a disclosure of ownership by BlackRock.

Future Outlook

The filing does not contain forward-looking statements or guidance from Sotera Health Co. It is a disclosure of beneficial ownership by BlackRock.

Management Comments

• "BlackRock, Inc. does hereby make, constitute and appoint each of Eric Andruczyk, Richard Cundiff, R. Andrew Dickson, III, Spencer Fleming, Laura Hildner, David Maryles, Christopher Meade, Charles Park, James Raby, Daniel Riemer, David Rothenberg and Brenda Schulz, acting severally, as its true and lawful attorneys-in-fact, for the purpose of, from time to time, executing, in its name and on its behalf and on behalf of its direct and indirect subsidiaries and affiliates, any and all documents..." (from Power of Attorney Exhibit)
• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities..." (from Schedule 13G Certification)

Industry Context

StockSavvy.ai notes that significant stake disclosures by major asset managers like BlackRock often signal sustained institutional interest in a company's sector. Sotera Health Co. operates in the healthcare sector, which is subject to ongoing regulatory scrutiny and innovation.

Stakeholder Impact

• Shareholders: The disclosure confirms a significant institutional investor's presence, which can be viewed positively by the market.
• Management: The filing reinforces that BlackRock's investment is in the ordinary course of business, not aimed at control changes.

Next Steps

• BlackRock will continue to monitor its investment in Sotera Health Co.
• Sotera Health Co. will continue its business operations as disclosed in its other filings.

Key Dates

Keywords

Sotera Health Co., BlackRock, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, Investment Management